Catégorie : Approches sociologiques de la consommation de Cannabis

Cannabis Domestication, Breeding History, Present-day Genetic Diversity, and Future Prospects, Robert C. Clarke and Mark D. Merlin, 2016

Cannabis Domestication, Breeding History, Present-day Genetic Diversity, and Future Prospects Robert C. Clarke and Mark D. Merlin CRITICAL REVIEWS IN PLANT SCIENCES, 2016, VOL. 35, NOS. 5–6, 293–327 Doi : 10.1080/07352689.2016.1267498   ABSTRACT Humans and the Cannabis plant share an intimate history spanning millennia. Humans spread Cannabis from its Eurasian homelands throughout much of the world, and, in concert with local climatic and human cultural parameters, created traditional landrace varieties (cultivars resulting from a combination of natural and farmer selection) with few apparent signs of domestication. Cannabis breeders combined populations from widely divergent geographical regions and gene pools to develop economically valuable fiber, seed, and drug cultivars, [...]

Lire la suite

Birth Outcomes of Neonates Exposed to Marijuana in Utero. A Systematic Review and Meta-analysis, Greg Marchand et al., 2022

Birth Outcomes of Neonates Exposed to Marijuana in Utero. A Systematic Review and Meta-analysis Greg Marchand, MD; Ahmed Taher Masoud, MD; Malini Govindan, MD; KellyWare, MS; Alexa King, BS; Stacy Ruther, BS; Giovanna Brazil, BS; Hollie Ulibarri, BS; Julia Parise, BS; Amanda Arroyo, BS; Catherine Coriell, BS; Sydnee Goetz, BS; Amitis Karrys, BS; Katelyn Sainz, MD JAMA Network Open, 2022, 5, (1), e2145653, 1-13. doi : 10.1001/jamanetworkopen.2021.45653   Abstract IMPORTANCE While some studies have found an association between marijuana use and adverse neonatal outcomes, results have not been consistent across all trials. OBJECTIVE To assess available data on neonatal outcomes in marijuana-exposed pregnancies. DATA SOURCES PubMed, Medline, ClinicalTrials.gov, [...]

Lire la suite

EDITORIAL : Cannabinoids in psychiatry : they are here to stay, Julia Jiyeon Woo et al., 2022

EDITORIAL : Cannabinoids in psychiatry : they are here to stay Julia Jiyeon Woo, Emma van Reekum, Sagnik Bhattacharyya and Zainab Samaan The British Journal of Psychiatry, 2022, 1-3. doi : 10.1192/bjp.2021.216   Summary Cannabinoids are commonly perceived by the public as safe and effective for improving mental health, despite limited evidence to support their use. We discuss reasons why cannabinoids may be particularly compelling for our patients and provide strategies for how psychiatrists can counsel and educate patients on the evidence regarding cannabinoids. Keywords : Cannabis; drug interactions and side-effects; drugs of dependence disorders; marijuana; education and training.   Vignette A young man sits in his psychiatrist’s office. After [...]

Lire la suite

Cannabinoids, Pain, and Opioid Use Reduction : The Importance of Distilling and Disseminating Existing Data, Kent E. Hutchison et al., 2019

Cannabinoids, Pain, and Opioid Use Reduction : The Importance of Distilling and Disseminating Existing Data Kent E. HUTCHISON, Sarah L. HAGERTY, Jeffrey GALINKIN, Angela D. BRYAN, L. Cinnamon BIDWELL Cannabis and Cannabinoid Research, 2019, 4, (3), 158-164. Doi : 10.1089/can.2018.0052   Abstract The high prevalence of chronic pain conditions combined with an over-reliance on opioid prescriptions has resulted in an opioid epidemic and a desperate need for solutions. There is some debate about whether cannabis might play a role in addressing chronic pain conditions as well as the opioid epidemic. Recent surveys suggest that a large number of people are using cannabis as a treatment for [...]

Lire la suite

L’INDISPENSABLE SUR… LE CANNABIDIOL (CBD), MILDECA, 2021

L’INDISPENSABLE SUR... LE CANNABIDIOL (CBD) MILDECA Mission interministérielle de lutte contre les drogues et les conduites addictives 2021   Qu’est-ce que le cannabidiol ? C’est : 􀂝 une des principales substances actives de type cannabinoïde de la plante de chanvre, au même titre que le THC (delta-9-tétrahydrocannabinol). On la trouve principalement au niveau de la fleur et des feuilles adjacentes. 􀂝 un composant, sous forme d’extrait, de médicaments ou de produits de consommation courante, dont seuls certains sont autorisés en France. Ce n’est pas : 􀂝 un stupéfiant. Le CBD reste tout de même une substance à effet psychoactif, qui peut avoir des interactions avec d'autres molécules, notamment des médicaments. 􀂝 une [...]

Lire la suite

Medical cannabis authorization and the risk of cardiovascular events : a longitudinal cohort study, Arsene Zongo et al.,

Medical cannabis authorization and the risk of cardiovascular events : a longitudinal cohort study Arsene Zongo, Cerina Lee, Jason R. B. Dyck, Jihane El‑Mourad, Elaine Hyshka, John G. Hanlon and Dean T. Eurich BMC Cardiovascular Disorders, 2021, 21, 426 doi : 10.1186/s12872-021-02229-6   Abstract Background : Cannabis is increasingly used for therapeutic purpose. However, its safety profile is not well known. This study assessed the risk of cardiovascular-related emergency department (ED) visit and hospitalization in adult patients authorized to use medical cannabis in Ontario, Canada from 2014 to 2017. Methods : This is a longitudinal cohort study of patients who received medical cannabis authorization and followedup in [...]

Lire la suite

Scoping Review and Meta-Analysis Suggests that Cannabis Use May Reduce Cancer Risk in the United State, Thomas M. Clark, 2021

Scoping Review and Meta-Analysis Suggests that Cannabis Use May Reduce Cancer Risk in the United States Thomas M. Clark Cannabis and Cannabinoid Research, 2021, Volume 6, Number 5, 413-434. Doi : 10.1089/can.2019.0095   Abstract Introduction:Cannabis smoke contains carcinogens similar to tobacco, in addition to compounds with antitumor activity. Cannabis use reduces the risk of obesity and cannabinoids inhibit chronic inflammation, known causes of cancer. The net effect of Cannabis use on cancer risk is not known. Objective: To examine the association between Cannabis use and cancer risk in the United States. Methods: Identify and analyze published data on cancer risk in Cannabis users. Results: A total of 55 data [...]

Lire la suite

Le Bus des femmes. Prostituées. Histoire d’une mobilisation Anne Coppel, Lydia Braggiotti, Malika Amaouche, 2020

Le Bus des femmes Prostituées. Histoire d'une mobilisation Anne Coppel, Lydia Braggiotti, Malika Amaouche Editions Anamosa, 2020, 152 pages N° ISBN : 979-10-95772-83-5 https://anamosa.fr/livre/le-bus-des-femmes/   En pleine épidémie de sida, des prostituées interpellent les pouvoirs publics sur leur santé et les conditions d’exercice de leur métier. Leur action, contemporaine de la création d’Act Up-Paris, conduira à la création du Bus des femmes en 1990. Un document historique rarissime qui témoigne de l’histoire des mobilisations citoyennes, un exemple unique de class action chez les prostituées. En 1990 à Paris, alors que l’épidémie de sida produit chaque jour plus de ravages, des prostituées se mobilisent et interpellent les pouvoirs publics. [...]

Lire la suite

National Retail Sales of Alcohol and Cannabis During the COVID-19 Pandemic in Canada, James MacKillop et al., 2021

National Retail Sales of Alcohol and Cannabis During the COVID-19 Pandemic in Canada James MacKillop, PhD; Alysha Cooper, MSc; Jean Costello, PhD JAMA Network Open, 2021, 4, (11), e2133076, 1-4. Doi : 10.1001/jamanetworkopen.2021.33076   Introduction There is concern that the societal consequences of the COVID-19 pandemic will be associated with increased substance use.1 Data to date have primarily been self-reported changes, but objective sales data may inform this question. Here, we examined national retail sales of alcohol and cannabis prior to and during the pandemic in Canada. Methods : Where applicable, the report for this economic evaluation is consistent with the Consolidated Health Economic Evaluation Reporting Standards [...]

Lire la suite

Faut-il légaliser le cannabis ?, Renaud Colson, Henri Bergeron, 2021

Faut-il légaliser le cannabis ? Renaud Colson, Henri Bergeron Editions First, "Pour les nuls", 2021, 120 pages.   Avant-propos Un ouvrage indispensable pour un débat complexe Le débat sur la légalisation du cannabis prend aujourd’hui une ampleur que nous n’avions pas connue auparavant pour différentes raisons qui tiennent à l’importance des consommations, à une meilleure connaissance scientifique des effets du produit, et à un réexamen de la politique publique dans de nombreux pays. Dès lors, en France aussi, la question du statut légal du cannabis n’est plus taboue. L’Assemblée nationale a même créé une mission parlementaire sur ce sujet, ce qui aurait été impensable il y a [...]

Lire la suite